SCHEMBL6206616

SCHEMBL6206616

CCOC(=O)c1sc(C(=O)OC)c(O)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 4/20 0.54
MEN1 O00255 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 3/20 0.50
GAA P10253 2/20 0.50
PKM P14618 1/20 0.50
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MC4R P32245 1/20 0.46
HPGD P15428 3/20 0.45
TSHR P16473 3/20 0.45
ALOX15 P16050 1/20 0.45
CYP1A2 P05177 1/20 0.45
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GSK3B P49841 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1141274 0.92 GAA (0.56) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL1726035 0.90 GAA (0.55) ALDH1A1KMT2AMAPTMEN1KDM4E
Lithium SCHEMBL7065338 0.90 GAA (0.55) ALDH1A1KMT2AMAPTMEN1KDM4E
Potassium SCHEMBL7063916 0.90 GAA (0.55) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL1086028 0.85 KMT2A (0.56) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL14650156 0.85 ALDH1A1 (0.51) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL1720659 0.83 KMT2A (0.54) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL13359464 0.83 GAA (0.49) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL10925924 0.82 MAPT (0.56) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL6205874 0.82 ESR1 (0.49) NPC1RAB9ATSHRCYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1298133-B1 Procedure for the alkylation of 3,4-dihydroxythiophene-2,5-dicarboxylic esters BAYER CHEMICALS AG (DE) 2005-01-19 EP claimed
US-6750354-B2 ALKYLATION OF 3,4- DIHYDROXYTHIOPHENE-2, 5-DICARBOXYLIC ESTERS OR THEIR ALKALI METAL OR ALKALINE EARTH METAL SALTS WITH ALKYLATING AGENTS IN A POLAR DILUENT IN THE PRESENCE OF QUATERNARY ONIUM SALTS BAYER AKTIENGESELLSCHAFT (DE) 2004-06-15 US claimed
US-20030097007-A1 Process for the alkylation of 3,4-dihydroxythiophene-2,5-dicarboxylic esters H. C. STARCK GMBH (DE) 2003-05-22 US claimed
US-6750354-B2 ALKYLATION OF 3,4- DIHYDROXYTHIOPHENE-2, 5-DICARBOXYLIC ESTERS OR THEIR ALKALI METAL OR ALKALINE EARTH METAL SALTS WITH ALKYLATING AGENTS IN A POLAR DILUENT IN THE PRESENCE OF QUATERNARY ONIUM SALTS BAYER AKTIENGESELLSCHAFT (DE) 2004-06-15 US disclosed
US-20030097007-A1 Process for the alkylation of 3,4-dihydroxythiophene-2,5-dicarboxylic esters H. C. STARCK GMBH (DE) 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097007-A1 Process for the alkylation of 3,4-dihydroxythiophene-2,5-dicarboxylic esters DIMT1, AS3MT, DDT ALDH1A1 915/4885KMT2A 195/4885MAPT 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.